Allied Conferences invites all the participants from all over the worldto attend ‘World Conference on STDs, STIs & HIV/AIDS’ which includes promptKeynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks,Poster Presentations and Exhibitions.
The field of HIV/AIDS and STDs (Sexually Transmitted Diseases) isgrowing rapidly and its development is making tremendous impacts in medicalsciences and pharmaceuticals. The importance and significance can be gauged bythe fact that it has made huge advancements over the course of time and iscontinuing to influence various sectors.
World Conference on STDs, STIs & HIV/AIDS is a leading Conference in USA.The program will explore new scientific knowledge and provides a platform for professionals and community members to participate in a structured dialogue on the major issues. The main objective will be to share scientific discoveries and clinical care on HIV and STDs, HIV diagnosis and therapy that would comprise various methods to diagnose HIV, HIV drug discovery, viral and bacterial STDs, STIs, like Herpes, HPV etc., strategies for HIV and STDs prevention, bioethics etc. As HIV/AIDS is an alarming concern throughout the world, STDs & HIV/AIDS-2017 will mainly focus on issues like Primary HIV Infection, Transmission and Eradication Issues & apart from this,the genetic approaches towards prevention of HIV & STDs, HIV Co-infection, HIV ongoing pharmaceutical design would cover the experimental drugs developed. STDs & HIV/AIDS-2017, lays perfect platform for Medical professionals, physicians, nurse-practitioners, pharmacists, psychologists, behavioral researchers, Health care professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Academicians who are working in the field of HIV & STDs medicine.
It is a great pleasureand an honor to welcome you with a warm invitation to attend the WorldConference on STDs, STIs & HIV/AIDS during July 26-27, 2017 Vancouver,Canada.
This Conference isorganized by the Allied Academics. This conference aims to provide aforum for researchers from various areas of Infectious diseases, HIV AIDSresearch, DNA analysis, method development and validation by providing aplatform for critical analysis of new data, and to share latest cutting-edgeresearch findings and results about all aspects of STDs, STIs research andcure.
The conference providesthe research works of infectious diseases expertise from various scientificbackgrounds and the same can be perceived by young researchers and students.STDs, STIs & HIV/AIDS Conferences mainly aims to promulgate knowledge inInfectious diseases, HIV AIDS, immunology research. Both Pharmaceutical andLife science in course of research work and therefore STDs & HIV/AIDS 2017would be a perfect venue to share and develop knowledge. We hope you will joinus to extend your research and take a little extra time to enjoy thespectacular and unique beauty of this region.
Human Immune-deficiency Virus (HIV) is one of the widespread, catastrophic disease among humans throughout the world. HIV is found to be most common ailment, especially in resource limited areas due to low health consciousness among the people and successful accomplishment of antiretroviral treatment program.
The vast majority of HIV infected people live in low- and middle- income countries. Since the start of epidemic, an evaluated 78 million people have been infected with HIV and 35 million people have extinct of AIDS-related illnesses. Some countries have attained a decline of 50% or more in current HIV infections among adults over the last 10 years, while many have made no noticeable progress. Yet others are experiencing worrying increases in new HIV infections.Despite these challenges, new global attempts have meant that the number of people sustaining HIV treatment has increased dramatically in recent years, particularly in resource-poor countries.
The global market for HIV therapeutics & diagnostics is expected to reach a value of $19.6 billion in 2017, along with a compound annual growth rate of 1.5% in the given forecast period. The following countries covered in the global study of HIV market such as, the US, Germany, Italy ,France, Spain, the UK, Canada and Japan are majorly dealing with HIV patients in large numbers. The generic types of HIV drugs include zidovudine, stavudine, and lamivudine – all of which constitutes 46 percent of the global HIV market.
The STDs Testing Market is forecast to reach $167.4 billion by 2020, accounting a CAGR of 8.5%. STDs are a grave issue globally, and are responsible for high incidence in adults and cause infertility in both men and women.